Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey
Manoj Murhekar, Tarun Bhatnagar, Sriram Selvaraju, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 3, pp. e257-e266
Open Access | Times Cited: 193

Showing 1-25 of 193 citing articles:

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S. Azman, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e598-e609
Open Access | Times Cited: 239
SARS‐CoV‐2 re‐infection risk in Austria
Stefan Pilz, Ali Chakeri, John P. A. Ioannidis, et al.
European Journal of Clinical Investigation (2021) Vol. 51, Iss. 4
Open Access | Times Cited: 150
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
Manoj Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
International Journal of Infectious Diseases (2021) Vol. 108, pp. 145-155
Open Access | Times Cited: 118
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination
Wan Yang, Jeffrey Shaman
Journal of The Royal Society Interface (2022) Vol. 19, Iss. 191
Open Access | Times Cited: 115
Asthma and COVID-19 risk: a systematic review and meta-analysis
Anthony Paulo Sunjaya, S. Allida, Gian Luca Di Tanna, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 3, pp. 2101209-2101209
Open Access | Times Cited: 97
Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 77
Risk of infection and transmission of SARS-CoV-2 among children and adolescents in households, communities and educational settings: A systematic review and meta-analysis
Omar Irfan, Li Jiang, Kun Tang, et al.
Journal of Global Health (2021) Vol. 11
Open Access | Times Cited: 77
Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June–July 2021: A population-based cross-sectional study
Manoj Murhekar, Tarun Bhatnagar, Jeromie Wesley Vivian Thangaraj, et al.
PLoS Medicine (2021) Vol. 18, Iss. 12, pp. e1003877-e1003877
Open Access | Times Cited: 75
Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections
Narendra Kumar, Shafeeq K Shahul Hameed, Giridhara R. Babu, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100717-100717
Open Access | Times Cited: 74
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Mahesh Shanker Dhar, Robin Marwal, Venkatraman Radhakrishnan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey
Antoine Nkuba-Ndaye, Sheila Makiala‐Mandanda, Emilande Guichet, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 5, pp. 882-890
Open Access | Times Cited: 48
Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis
Samiran Panda, Sandip Mandal, Nimalan Arinaminpathy, et al.
The Indian Journal of Medical Research (2021) Vol. 153, Iss. 5, pp. 522-522
Open Access | Times Cited: 48
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey
Mohamed Bailor Barrie, Sulaiman Lakoh, J. Daniel Kelly, et al.
BMJ Global Health (2021) Vol. 6, Iss. 11, pp. e007271-e007271
Open Access | Times Cited: 47
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination
Wan Yang, Jeffrey Shaman
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 45
Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya
Anthony Etyang, Ruth Lucinde, Henry Karanja, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 2, pp. 288-293
Open Access | Times Cited: 44
Simple methods for early warnings of COVID-19 surges: Lessons learned from 21 months of wastewater and clinical data collection in Detroit, Michigan, United States
Liang Zhao, Yangyang Zou, Randy E. David, et al.
The Science of The Total Environment (2022) Vol. 864, pp. 161152-161152
Open Access | Times Cited: 28
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Syndromic Indicators and Wastewater Surveillance of SARS-CoV-2 – A Population-Based Longitudinal Study from South India
Deodatt M. Suryawanshi, Perumal Vanamail, Suguna Anzbhagan, et al.
Deleted Journal (2025)
Closed Access
Seroepidemiological study of SARS-CoV-2 infection in East Java, Indonesia
Ni Luh Ayu Megasari, Takako Utsumi, Laura Navika Yamani, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251234-e0251234
Open Access | Times Cited: 38
A comparison of five epidemiological models for transmission of SARS-CoV-2 in India
Soumik Purkayastha, Rupam Bhattacharyya, Ritwik Bhaduri, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Battling COVID‐19 with dysfunctional federalism: Lessons from India
Abishek Choutagunta, G.P. Manish, Shruti Rajagopalan
Southern Economic Journal (2021) Vol. 87, Iss. 4, pp. 1267-1299
Open Access | Times Cited: 35
Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis
Nuzrath Jahan, Adarsha Brahma, Muthusamy Santhosh Kumar, et al.
International Journal of Infectious Diseases (2021) Vol. 116, pp. 59-67
Open Access | Times Cited: 33
The seroprevalence of severe acute respiratory syndrome coronavirus 2 in Delhi, India: a repeated population-based seroepidemiological study
Nandini Sharma, Pragya Sharma, Saurav Basu, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2021) Vol. 116, Iss. 3, pp. 242-251
Open Access | Times Cited: 32
Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience
Maxwell Salvatore, Soumik Purkayastha, Lakshmi Ganapathi, et al.
Science Advances (2022) Vol. 8, Iss. 24
Open Access | Times Cited: 23
Serological prevalence of SARS-CoV-2 antibody among children and young age group (between 2 and 17 years) in India: An interim result from a large multicentric population-based seroepidemiological study
Puneet Misra, Shashi Kant, Randeep Guleria, et al.
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 6, pp. 2816-2823
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top